The number of patients with inflammatory bowel disease (IBD) is increasing worldwide.
Endoscopy is the gold standard to assess the condition of IBD. The problem with this …

Inflammatory bowel disease (IBD) is a chronic disease mostly involved with intestine with
unknown etiology. Diagnosis, evaluation of severity, and prognosis are still present as …

There is currently no gold standard test for the diagnosis of inflammatory bowel disease
(IBD). Physicians must rely on a number of diagnostic tools including clinical and …

Background: Inflammatory bowel disease (IBD) is a chronically relapsing disease with a
continuous need for proactive monitoring to decide appropriate treatments and follow-up …

Introduction: Blood C-reactive protein (CRP) and fecal calprotectin levels are routinely
measured as surrogate markers of disease activity in Inflammatory Bowel Disease (IBD), but …

There is increasing interest in the concept of 'treat‐to‐target'in inflammatory bowel disease
as a mechanism to standardize management and prevent complications. While clinical …

There is currently no single test available to confidently diagnose cases of inflammatory
bowel disease (IBD). Physicians rely on a number of diagnostic tools, including clinical …

Diagnosis and prognosis of inflammatory bowel disease (IBD)—a chronic inflammation that
affects the gastrointestinal tract of patients—are challenging, as most clinical symptoms are …

Diagnosis and monitoring of inflammatory bowel diseases rely on clinical, endoscopic, and
radiologic parameters. Inflammatory biomarkers have been investigated as a surrogate …

The role of biomarkers in the diagnosis of inflammatory bowel disease is not fully
characterized. C-reactive protein has a short half-life and elevates quickly after the onset of …